Mainstay Capital Management LLC Gilead Sciences, Inc. Transaction History

Mainstay Capital Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $1.02 Million - $1.16 Million	-17,017 Closed	0 $0
Q4 2020 Mar 04, 2021	SELL	$56.65 - $64.55 $147,176 - $167,700	-2,598 Reduced 13.24%	17,017 $991,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $125,131 - $157,331	-2,015 Reduced 9.32%	19,615 $1.24 Million
Q2 2020 Jul 23, 2020	BUY	$72.34 - $84.0 $1.56 Million - $1.82 Million	21,630 New	21,630 $1.66 Million
Q4 2019 Jan 21, 2020	SELL	$61.62 - $67.78 $1.18 Million - $1.3 Million	-19,197 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$62.51 - $69.0 $81,575 - $90,045	1,305 Added 7.29%	19,197 $1.22 Million
Q2 2019 Aug 07, 2019	BUY	$61.87 - $69.38 $208,811 - $234,157	3,375 Added 23.25%	17,892 $1.21 Million
Q1 2019 Apr 23, 2019	SELL	$62.53 - $70.05 $117,243 - $131,343	-1,875 Reduced 11.44%	14,517 $943,000
Q4 2018 Feb 08, 2019	BUY	$60.54 - $79.0 $643,842 - $840,165	10,635 Added 184.73%	16,392 $1.02 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $512,859 - $567,829	-7,195 Reduced 55.55%	5,757 $444,000
Q2 2018 Aug 24, 2018	SELL	$64.88 - $75.68 $43.6 Million - $50.8 Million	-671,512 Reduced 98.11%	12,952 $918,000
Q2 2018 Aug 23, 2018	BUY	$64.88 - $75.68 $43.6 Million - $50.8 Million	671,792 Added 5301.39%	684,464 $9.85 Million
Q1 2018 May 10, 2018	BUY	$72.84 - $88.8 $177,001 - $215,784	2,430 Added 23.73%	12,672 $955,000
Q4 2017 Mar 28, 2018	BUY	$71.15 - $83.52 $728,718 - $855,411	10,242	10,242 $734,000

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Mainstay Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mainstay Capital Management LLC with notifications on news.